ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr | ₹10,411 Cr | ₹9,013 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹14,060 Cr |
Mar2023 | ₹12,454 Cr |
Mar2022 | ₹12,760 Cr |
Mar2021 | ₹10,411 Cr |
Mar2020 | ₹9,013 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹14,060 Cr | 12.89 | |
Mar2023 | ₹12,454 Cr | -2.40 | |
Mar2022 | ₹12,760 Cr | 22.56 | |
Mar2021 | ₹10,411 Cr | 15.52 | |
Mar2020 | ₹9,013 Cr | - |
Compare Total Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹59,793.4 Cr | 4.3% | 4.4% | -7.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 4.3% |
4.4% |
-7.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses